Legionnaire Disease Testing Market Size, Share & Trends 2032

Legionnaire Disease Testing Market Outlook

[342 Pages Report] The legionnaire disease testing market is projected to register a CAGR of 9% during the forecast period, up from US$ 292 Mn in 2022 to reach a valuation of US$ 819.5 Mn by 2032.

The legionnaire disease testing market is anticipated to show promising growth prospects during the forecast period as a result of growing competition. New competitors are offering a variety of options at reasonable pricing to fulfil the demand for legionnaire disease testing making it more accessible to customers in the global legionnaire disease testing market.

Report Attribute	Details
Estimated Base Year Value (2021)	US$ 267 Million
Expected Market Value (2022)	US$ 292 Million
Anticipated Forecast Value (2032)	US$ 819.5 Million
Projected Growth Rate (2022-2032)	9% CAGR

Sales of legionnaire disease testing are expected to rise significantly. In addition to this, sales of legionnaire disease testing are rising on account for US$ 411.3 Mn by 2026. Increasing sales of legionnaire disease testing are also projected to contribute to the growth of the legionnaire disease testing market share.

Increasing public knowledge about effective illness detection and management has resulted from increased government programmes and financing. Furthermore, the worldwide legionnaire disease testing market is being driven by an increase in the need for better diagnostic methods as the prevalence rate rises.

The legionnaire illness testing market may expand as the adoption rate of legionnaire disease testing rises. The legionnaire disease testing market is also predicted to rise due to increased R&D initiatives for technology development for different illnesses.

The shortage of qualified specialists, on the other hand, is likely to stifle the legionnaire disease testing market expansion. Lack of resources and ignorance about infection are also predicted to stymie the sales of legionnaire disease testing market expansion.

Manufacturers in the legionnaire disease testing market get a big platform from which to serve the whole demand for legionnaire disease testing. The worldwide sales of legionnaire disease testing is seeing increased competition. With growing competition, new competitors are offering a variety of options at reasonable pricing, fulfilling the demand for legionnaire disease testing more accessible to customers.

Some of the key players present in the global legionnaire disease testing market are Beckman Coulter, Inc.; Albagaia Ltd.; Bio-Rad Laboratories, Inc.; Abbott Laboratories.; F. Hoffmann-La Roche AG; Thermo Fischer Scientific, Inc.; Becton, Dickinson and Company; Aquacert Ltd, BioMérieux SA; Idexx Laboratories Inc.; and others.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Key Drivers to the Legionnaire Disease Testing Market Share?

According to the World Health Organization, 75-80% of the population is 50 years old or older, with 65-70% of the population being male. The male population is more susceptible to the demand for legionnaire disease testing than the female population.

Furthermore, the elderly are at a higher risk of legionnaire disease testing and are more likely to get infected. Globally, however, the advancement of innovative testing technologies is increasing. Increased knowledge of present and evolving technology is also helping to boost acceptance of the new testing method, which is projected to open up significant sales of legionnaire disease testing.

However, a scarcity of qualified healthcare providers, as well as a lack of knowledge of the condition and the inability to diagnose it at an early stage, may stymie the demand for legionnaire disease testing market expansion. Furthermore, the absence of improved healthcare facilities may limit the legionnaire disease testing market growth.

Which is the Leading Region in the Legionnaire Disease Testing Market?

The sales of legionnaire disease testing market in Asia-Pacific are predicted to expand rapidly in the next years. This is owing to the existence of a huge population of people who are at high risk. In addition, a lack of knowledge on how to treat infectious diseases is adding to the region's growing population at risk.

The legionnaire disease testing market is predicted to increase rapidly as a result of this. Because of the region's excellent healthcare infrastructure and extensive research and development activities, the North American legionnaire disease testing market is likely to be the most prominent. Due to the availability of qualified researchers and a strong acceptance rate in the area, Europe will rank second in the sales of legionnaire disease testing market.

Due to a scarcity of qualified specialists in the region, the legionnaire disease testing market in Latin America is predicted to rise steadily. Due to a lack of facilities and public knowledge of legionnaire illness, the Middle East and Africa are likely to be the least profitable hence a decline in the demand for legionnaire disease testing.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Who are the Key Players in the Legionnaire Disease Testing Market?

The report consists of key players, contributing to the legionnaire disease testing market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions. This exclusive report analyzes the competitive landscape and legionnaire disease testing market share acquired by players to strengthen their market position.

Recent developments of the Legionnaire Disease Testing Market

June 2021 - Phigenics has unveiled a new diagnostic tool. To detect Legionella serogroup and species in building water systems, Phigenics Validation Test (PVT) Next Day LegiPlex PCR (Polymerase Chain Reaction). It provides quick findings, and the test met the International Standards Organization's (ISO) requirements for a limit of detection and specificity.
March 2021 – IDEXX released the findings of research conducted by WLN, a water quality and technology firm. The IDEXX Legiolert test was compared to the Dutch national reference technique for detecting Legionella pneumophila in the research.
A two-day free virtual conference on legionnaires' disease hazards during and after a covid-19 pandemic was held by the Alliance to Prevent Legionnaires' Disease, a national nonprofit organisation, in August 2020. This virtual conference aimed to increase public awareness of the effective management of risk factors associated with watery Legionnaires' disease.

Report Scope

Report Attribute	Details
Growth rate	CAGR of 9% from 2022 to 2032
Base year for estimation	2021
Historical data	2015 - 2020
Forecast period	2022 - 2032
Quantitative units	Revenue in USD Million and CAGR from 2022 to 2032
Report coverage	Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis
Segments covered	Product type, diagnostic test, end user, region
Regional scope	North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand
Country scope	U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Key companies profiled	Beckman Coulter, Inc.; Albagaia Ltd.; Bio-Rad Laboratories, Inc.; Abbott Laboratories.; F. Hoffmann-La Roche AG; Thermo Fischer Scientific, Inc.; Becton, Dickinson and Company; Aquacert Ltd, BioMérieux SA; Idexx Laboratories Inc.; and others
Customization scope	Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail of customized purchase options to meet your exact research needs.

Key Segments For Legionnaire Disease Testing Market

Legionnaire Disease Testing Segmentation by Product Type:

Devices
Polymerase Chain Reaction System
Sequencer System
Test Kits
Assay Based Test Kits
Rapid Test Kits

Legionnaire Disease Testing Segmentation by Diagnostic Test:

Culture Method
Urinary Antigen Test
Paired Serology
Direct Fluorescent Antibody (DFA) Stain
Polymerase Chain Reaction (PCR)
Combination Testing (Culture and Urinary Antigen Tests)

Legionnaire Disease Testing Segmentation by End User:

Hospitals
Diagnostic Laboratories
Clinical Research Centers
Academic Institutes
Research Centers
Others

Legionnaire Disease Testing Segmentation by Region:

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
East Asia (China, Japan, South Korea)
South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
Oceania (Australia, New Zealand)
Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

Frequently Asked Questions

What is the Growth Outlook for the Legionnaire Disease Testing Market?

The legionnaire disease testing market is predicted to register a CAGR of 9% during the forecast period.

Who are the Key Players in the Legionnaire Disease Testing Market?

Key players holding substantial legionnaire disease testing market share include Beckman Coulter, Inc.; Albagaia Ltd.; Bio-Rad Laboratories, Inc.; Abbott Laboratories.; Aquacert Ltd, BioMérieux SA; Idexx Laboratories Inc.; and others

What is the Future of the Legionnaire Disease Testing Market?

As per the analysis, the legionnaire disease testing market share is likely to be US$ 411.3 Mn by 2026.

Which is the Key Driver in the Legionnaire Disease Testing Market?

Demand for legionnaire disease testing is likely to rise being driven by an increase in the need for better diagnostic methods as the prevalence rate rises.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Product Life Cycle Analysis

3.5. Supply Chain Analysis

3.5.1. Supply Side Participants and their Roles

3.5.1.1. Producers

3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

3.5.1.3. Wholesalers and Distributors

3.5.2. Value Added and Value Created at Node in the Supply Chain

3.5.3. List of Raw Material Suppliers

3.5.4. List of Existing and Potential Buyer’s

3.6. Investment Feasibility Matrix

3.7. Value Chain Analysis

3.7.1. Profit Margin Analysis

3.7.2. Wholesalers and Distributors

3.7.3. Retailers

3.8. PESTLE and Porter’s Analysis

3.9. Regulatory Landscape

3.9.1. By Key Regions

3.9.2. By Key Countries

3.10. Regional Parent Market Outlook

3.11. Production and Consumption Statistics

3.12. Import and Export Statistics

4. Global Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast, 2022-2032

4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021

4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2017-2021

5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2022-2032

5.3.1. Devices

5.3.2. Polymerase Chain Reaction System

5.3.3. Sequencer System

5.3.4. Test Kits

5.3.5. Assay Based Test Kits

5.3.6. Rapid Test Kits

5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021

5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

6. Global Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Diagnostic Test

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Diagnostic Test, 2017-2021

6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Diagnostic Test, 2022-2032

6.3.1. Culture Method

6.3.2. Urinary Antigen Test

6.3.3. Paired Serology

6.3.4. Direct Fluorescent Antibody Stain

6.3.5. Polymerase Chain Reaction

6.3.6. Combination Testing

6.4. Y-o-Y Growth Trend Analysis By Diagnostic Test, 2017-2021

6.5. Absolute $ Opportunity Analysis By Diagnostic Test, 2022-2032

7. Global Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End User

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021

7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032

7.3.1. Hospitals

7.3.2. Diagnostic Laboratories

7.3.3. Clinical Research Centers

7.3.4. Academic Institutes

7.3.5. Research Centers

7.3.6. Others

7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

7.5. Absolute $ Opportunity Analysis By End User, 2022-2032

8. Global Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021

8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032

8.3.1. North America

8.3.2. Latin America

8.3.3. Europe

8.3.4. East Asia

8.3.5. South Asia & Pacific

8.3.6. MEA

8.4. Market Attractiveness Analysis By Region

9. North America Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

9.2.1. By Country

9.2.1.1. U.S.

9.2.1.2. Canada

9.2.2. By Product Type

9.2.3. By Diagnostic Test

9.2.4. By End User

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Product Type

9.3.3. By Diagnostic Test

9.3.4. By End User

9.4. Key Takeaways

10. Latin America Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

10.2.1. By Country

10.2.1.1. Mexico

10.2.1.2. Brazil

10.2.1.3. Rest of Latin America

10.2.2. By Product Type

10.2.3. By Diagnostic Test

10.2.4. By End User

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Product Type

10.3.3. By Diagnostic Test

10.3.4. By End User

10.4. Key Takeaways

11. Europe Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

11.2.1. By Country

11.2.1.1. Germany

11.2.1.2. Italy

11.2.1.3. France

11.2.1.4. U.K.

11.2.1.5. Spain

11.2.1.6. BENELUX

11.2.1.7. Russia

11.2.1.8. Rest of Europe

11.2.2. By Product Type

11.2.3. By Diagnostic Test

11.2.4. By End User

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Product Type

11.3.3. By Diagnostic Test

11.3.4. By End User

11.4. Key Takeaways

12. East Asia Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

12.2.1. By Country

12.2.1.1. China

12.2.1.2. Japan

12.2.1.3. South Korea

12.2.2. By Product Type

12.2.3. By Diagnostic Test

12.2.4. By End User

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Product Type

12.3.3. By Diagnostic Test

12.3.4. By End User

12.4. Key Takeaways

13. South Asia & Pacific Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

13.2.1. By Country

13.2.1.1. India

13.2.1.2. ASEAN

13.2.1.3. Australia and New Zealand

13.2.1.4. Rest of South Asia & Pacific

13.2.2. By Product Type

13.2.3. By Diagnostic Test

13.2.4. By End User

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Product Type

13.3.3. By Diagnostic Test

13.3.4. By End User

13.4. Key Takeaways

14. MEA Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

14.2.1. By Country

14.2.1.1. GCC Countries

14.2.1.2. Turkey

14.2.1.3. South Africa

14.2.1.4. Rest of MEA

14.2.2. By Product Type

14.2.3. By Diagnostic Test

14.2.4. By End User

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Product Type

14.3.3. By Diagnostic Test

14.3.4. By End User

14.4. Key Takeaways

15. Key Countries Legionnaire Disease Testing Market Analysis

15.1. U.S.

15.1.1. Pricing Analysis

15.1.2. Market Share Analysis, 2021

15.1.2.1. By Product Type

15.1.2.2. By Diagnostic Test

15.1.2.3. By End User

15.2. Canada

15.2.1. Pricing Analysis

15.2.2. Market Share Analysis, 2021

15.2.2.1. By Product Type

15.2.2.2. By Diagnostic Test

15.2.2.3. By End User

15.3. Mexico

15.3.1. Pricing Analysis

15.3.2. Market Share Analysis, 2021

15.3.2.1. By Product Type

15.3.2.2. By Diagnostic Test

15.3.2.3. By End User

15.4. Brazil

15.4.1. Pricing Analysis

15.4.2. Market Share Analysis, 2021

15.4.2.1. By Product Type

15.4.2.2. By Diagnostic Test

15.4.2.3. By End User

15.5. Germany

15.5.1. Pricing Analysis

15.5.2. Market Share Analysis, 2021

15.5.2.1. By Product Type

15.5.2.2. By Diagnostic Test

15.5.2.3. By End User

15.6. Italy

15.6.1. Pricing Analysis

15.6.2. Market Share Analysis, 2021

15.6.2.1. By Product Type

15.6.2.2. By Diagnostic Test

15.6.2.3. By End User

15.7. France

15.7.1. Pricing Analysis

15.7.2. Market Share Analysis, 2021

15.7.2.1. By Product Type

15.7.2.2. By Diagnostic Test

15.7.2.3. By End User

15.8. U.K.

15.8.1. Pricing Analysis

15.8.2. Market Share Analysis, 2021

15.8.2.1. By Product Type

15.8.2.2. By Diagnostic Test

15.8.2.3. By End User

15.9. Spain

15.9.1. Pricing Analysis

15.9.2. Market Share Analysis, 2021

15.9.2.1. By Product Type

15.9.2.2. By Diagnostic Test

15.9.2.3. By End User

15.10. BENELUX

15.10.1. Pricing Analysis

15.10.2. Market Share Analysis, 2021

15.10.2.1. By Product Type

15.10.2.2. By Diagnostic Test

15.10.2.3. By End User

15.11. Russia

15.11.1. Pricing Analysis

15.11.2. Market Share Analysis, 2021

15.11.2.1. By Product Type

15.11.2.2. By Diagnostic Test

15.11.2.3. By End User

15.12. China

15.12.1. Pricing Analysis

15.12.2. Market Share Analysis, 2021

15.12.2.1. By Product Type

15.12.2.2. By Diagnostic Test

15.12.2.3. By End User

15.13. Japan

15.13.1. Pricing Analysis

15.13.2. Market Share Analysis, 2021

15.13.2.1. By Product Type

15.13.2.2. By Diagnostic Test

15.13.2.3. By End User

15.14. South Korea

15.14.1. Pricing Analysis

15.14.2. Market Share Analysis, 2021

15.14.2.1. By Product Type

15.14.2.2. By Diagnostic Test

15.14.2.3. By End User

15.15. India

15.15.1. Pricing Analysis

15.15.2. Market Share Analysis, 2021

15.15.2.1. By Product Type

15.15.2.2. By Diagnostic Test

15.15.2.3. By End User

15.16. ASEAN

15.16.1. Pricing Analysis

15.16.2. Market Share Analysis, 2021

15.16.2.1. By Product Type

15.16.2.2. By Diagnostic Test

15.16.2.3. By End User

15.17. Australia and New Zealand

15.17.1. Pricing Analysis

15.17.2. Market Share Analysis, 2021

15.17.2.1. By Product Type

15.17.2.2. By Diagnostic Test

15.17.2.3. By End User

15.18. GCC Countries

15.18.1. Pricing Analysis

15.18.2. Market Share Analysis, 2021

15.18.2.1. By Product Type

15.18.2.2. By Diagnostic Test

15.18.2.3. By End User

15.19. Turkey

15.19.1. Pricing Analysis

15.19.2. Market Share Analysis, 2021

15.19.2.1. By Product Type

15.19.2.2. By Diagnostic Test

15.19.2.3. By End User

15.20. South Africa

15.20.1. Pricing Analysis

15.20.2. Market Share Analysis, 2021

15.20.2.1. By Product Type

15.20.2.2. By Diagnostic Test

15.20.2.3. By End User

16. Market Structure Analysis

16.1. Competition Dashboard

16.2. Competition Benchmarking

16.3. Market Share Analysis of Top Players

16.3.1. By Regional

16.3.2. By Product Type

16.3.3. By Diagnostic Test

16.3.4. By End User

17. Competition Analysis

17.1. Competition Deep Dive

17.1.1. Beckman Coulter, Inc.

17.1.1.1. Overview

17.1.1.2. Product Portfolio

17.1.1.3. Profitability by Market Segments

17.1.1.4. Sales Footprint

17.1.1.5. Strategy Overview

17.1.1.5.1. Marketing Strategy

17.1.1.5.2. Product Strategy

17.1.1.5.3. Channel Strategy

17.1.2. Bio-Rad Laboratories, Inc.

17.1.2.1. Overview

17.1.2.2. Product Portfolio

17.1.2.3. Profitability by Market Segments

17.1.2.4. Sales Footprint

17.1.2.5. Strategy Overview

17.1.2.5.1. Marketing Strategy

17.1.2.5.2. Product Strategy

17.1.2.5.3. Channel Strategy

17.1.3. Abbott Laboratories.

17.1.3.1. Overview

17.1.3.2. Product Portfolio

17.1.3.3. Profitability by Market Segments

17.1.3.4. Sales Footprint

17.1.3.5. Strategy Overview

17.1.3.5.1. Marketing Strategy

17.1.3.5.2. Product Strategy

17.1.3.5.3. Channel Strategy

17.1.4. F. Hoffmann-La Roche AG

17.1.4.1. Overview

17.1.4.2. Product Portfolio

17.1.4.3. Profitability by Market Segments

17.1.4.4. Sales Footprint

17.1.4.5. Strategy Overview

17.1.4.5.1. Marketing Strategy

17.1.4.5.2. Product Strategy

17.1.4.5.3. Channel Strategy

17.1.5. Thermo Fischer Scientific, Inc.

17.1.5.1. Overview

17.1.5.2. Product Portfolio

17.1.5.3. Profitability by Market Segments

17.1.5.4. Sales Footprint

17.1.5.5. Strategy Overview

17.1.5.5.1. Marketing Strategy

17.1.5.5.2. Product Strategy

17.1.5.5.3. Channel Strategy

17.1.6. Becton, Dickinson and Company

17.1.6.1. Overview

17.1.6.2. Product Portfolio

17.1.6.3. Profitability by Market Segments

17.1.6.4. Sales Footprint

17.1.6.5. Strategy Overview

17.1.6.5.1. Marketing Strategy

17.1.6.5.2. Product Strategy

17.1.6.5.3. Channel Strategy

17.1.7. Aquacert Ltd

17.1.7.1. Overview

17.1.7.2. Product Portfolio

17.1.7.3. Profitability by Market Segments

17.1.7.4. Sales Footprint

17.1.7.5. Strategy Overview

17.1.7.5.1. Marketing Strategy

17.1.7.5.2. Product Strategy

17.1.7.5.3. Channel Strategy

17.1.8. BioMérieux SA

17.1.8.1. Overview

17.1.8.2. Product Portfolio

17.1.8.3. Profitability by Market Segments

17.1.8.4. Sales Footprint

17.1.8.5. Strategy Overview

17.1.8.5.1. Marketing Strategy

17.1.8.5.2. Product Strategy

17.1.8.5.3. Channel Strategy

17.1.9. Idexx Laboratories Inc.

17.1.9.1. Overview

17.1.9.2. Product Portfolio

17.1.9.3. Profitability by Market Segments

17.1.9.4. Sales Footprint

17.1.9.5. Strategy Overview

17.1.9.5.1. Marketing Strategy

17.1.9.5.2. Product Strategy

17.1.9.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Legionnaire Disease Testing Market

Legionnaire Disease Testing Market by Product Type, Diagnostic Test, End User & Region - Forecast 2022 – 2032

Legionnaire Disease Testing Market Outlook

What are the Key Drivers to the Legionnaire Disease Testing Market Share?

Which is the Leading Region in the Legionnaire Disease Testing Market?

Who are the Key Players in the Legionnaire Disease Testing Market?

Recent developments of the Legionnaire Disease Testing Market

Report Scope

Key Segments For Legionnaire Disease Testing Market

Legionnaire Disease Testing Segmentation by Product Type:

Legionnaire Disease Testing Segmentation by Diagnostic Test:

Legionnaire Disease Testing Segmentation by End User:

Legionnaire Disease Testing Segmentation by Region:

Frequently Asked Questions

What is the Growth Outlook for the Legionnaire Disease Testing Market?

Who are the Key Players in the Legionnaire Disease Testing Market?

What is the Future of the Legionnaire Disease Testing Market?

Which is the Key Driver in the Legionnaire Disease Testing Market?

Table of Content

Recommendations

Infectious Disease Diagnostics Market

Addison Disease Testing Market

Veterinary Infectious Disease Diagnostics Market